MYD88 and Cognitive impairment: Deletion of the upstream activator of NF-κB, myeloid differentiation primary response 88 (MyD88), from astrocytes reduced pro-inflammatory responses, synaptic toxicity, and cognitive impairment caused by Aβ53.